ArticleLeukemia research reports2016

An ETV6-ABL1 fusion in a patient with chronic myeloproliferative neoplasm: Initial response to Imatinib followed by rapid transformation into ALL.

Purvi M Kakadia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.